Half-year report · HY
3840.TEDINET S100X3IZ
Period2025-04-01 → 2025-09-30
Filed2025-11-13
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥1.3bn | 2025-04-01 → 2025-09-30 | Cons. | Net sales |
| Revenue | ¥2.3bn | 2024-04-01 → 2025-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥1.1bn | 2024-04-01 → 2024-09-30 | Cons. | Net sales |
| Operating income | −¥323m | 2025-04-01 → 2025-09-30 | Cons. | Operating income |
| Operating income | −¥84m | 2024-04-01 → 2024-09-30 | Cons. | Operating income |
| Ordinary income | −¥324m | 2025-04-01 → 2025-09-30 | Cons. | Ordinary income |
| Ordinary income | −¥229m | 2024-04-01 → 2025-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | −¥78m | 2024-04-01 → 2024-09-30 | Cons. | Ordinary income |
| Profit before tax | −¥321m | 2025-04-01 → 2025-09-30 | Cons. | Income before income taxes |
| Profit before tax | −¥79m | 2024-04-01 → 2024-09-30 | Cons. | Income before income taxes |
| Net income (owners) | −¥320m | 2025-04-01 → 2025-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | −¥277m | 2024-04-01 → 2025-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | −¥82m | 2024-04-01 → 2024-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | −¥320m | 2025-04-01 → 2025-09-30 | Cons. | Profit loss |
| Net income | −¥82m | 2024-04-01 → 2024-09-30 | Cons. | Profit loss |
| Total assets | ¥3.2bn | at 2025-09-30 | Cons. | Assets |
| Total assets | ¥3.3bn | at 2025-03-31 | Cons. | Assets |
| Total assets | ¥2.1bn | at 2024-09-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥647m | at 2025-09-30 | Cons. | Liabilities |
| Total liabilities | ¥777m | at 2025-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥2.5bn | at 2025-09-30 | Cons. | Net assets |
| Net assets / equity | ¥2.5bn | at 2025-03-31 | Cons. | Net assets |
| Net assets / equity | ¥1.4bn | at 2024-09-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥98m | at 2025-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥155m | at 2025-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥98m | at 2025-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥155m | at 2025-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥190m | at 2024-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥297m | at 2024-03-31v | Cons. | Cash and cash equivalents |
| Operating cash flow | −¥182m | 2025-04-01 → 2025-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | −¥539m | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | −¥248m | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥199m | 2025-04-01 → 2025-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥525m | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥432m | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | ¥324m | 2025-04-01 → 2025-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥914m | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥573m | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥-4.25 | 2025-04-01 → 2025-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-4.36 | 2024-04-01 → 2025-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-1.38 | 2024-04-01 → 2024-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 79.0% | at 2025-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 75.5% | at 2025-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 65.9% | at 2024-09-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 46
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2025-04-01 → 2025-09-30 | −¥4m |
| Reconciling Itemsreconciling | revenue intersegment | 2025-04-01 → 2025-09-30 | −¥4m |
| Reconciling Itemsreconciling | segment profit | 2025-04-01 → 2025-09-30 | −¥74m |
| AI Technologyreportable segment | revenue | 2025-04-01 → 2025-09-30 | ¥22m |
| AI Technologyreportable segment | revenue external | 2025-04-01 → 2025-09-30 | ¥22m |
| AI Technologyreportable segment | segment profit | 2025-04-01 → 2025-09-30 | −¥67m |
| Beauty And Wellness Businessreportable segment | revenue | 2025-04-01 → 2025-09-30 | ¥429m |
| Beauty And Wellness Businessreportable segment | revenue external | 2025-04-01 → 2025-09-30 | ¥429m |
| Beauty And Wellness Businessreportable segment | segment profit | 2025-04-01 → 2025-09-30 | −¥39m |
| Cosmetics Businessreportable segment | revenue | 2025-04-01 → 2025-09-30 | ¥539m |
| Cosmetics Businessreportable segment | revenue external | 2025-04-01 → 2025-09-30 | ¥539m |
| Cosmetics Businessreportable segment | segment profit | 2025-04-01 → 2025-09-30 | −¥84m |
| Investment Businessreportable segment | revenue | 2025-04-01 → 2025-09-30 | ¥20m |
| Investment Businessreportable segment | revenue external | 2025-04-01 → 2025-09-30 | ¥20m |
| Investment Businessreportable segment | segment profit | 2025-04-01 → 2025-09-30 | ¥18m |
| Market Expansion Businessreportable segment | revenue | 2025-04-01 → 2025-09-30 | ¥1m |
| Market Expansion Businessreportable segment | revenue external | 2025-04-01 → 2025-09-30 | ¥1m |
| Market Expansion Businessreportable segment | revenue intersegment | 2025-04-01 → 2025-09-30 | ¥50,000 |
| Market Expansion Businessreportable segment | segment profit | 2025-04-01 → 2025-09-30 | −¥21m |
| Regenerative Medicine Related Businessreportable segment | revenue | 2025-04-01 → 2025-09-30 | ¥258m |
| Regenerative Medicine Related Businessreportable segment | revenue external | 2025-04-01 → 2025-09-30 | ¥254m |
| Regenerative Medicine Related Businessreportable segment | revenue intersegment | 2025-04-01 → 2025-09-30 | ¥4m |
| Regenerative Medicine Related Businessreportable segment | segment profit | 2025-04-01 → 2025-09-30 | −¥26m |
| Sustainable Businessreportable segment | revenue | 2025-04-01 → 2025-09-30 | ¥919,000 |
| Sustainable Businessreportable segment | revenue external | 2025-04-01 → 2025-09-30 | ¥919,000 |
| Sustainable Businessreportable segment | segment profit | 2025-04-01 → 2025-09-30 | −¥30m |
| —segment total | revenue | 2025-04-01 → 2025-09-30 | ¥1.3bn |
| —segment total | revenue external | 2025-04-01 → 2025-09-30 | ¥1.3bn |
| —segment total | revenue intersegment | 2025-04-01 → 2025-09-30 | ¥4m |
| —segment total | segment profit | 2025-04-01 → 2025-09-30 | −¥249m |
| Reconciling Itemsreconciling | segment profit | 2024-04-01 → 2024-09-30 | −¥58m |
| Beauty And Wellness Businessreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥500m |
| Beauty And Wellness Businessreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥500m |
| Beauty And Wellness Businessreportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥10m |
| Cosmetics Businessreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥439m |
| Cosmetics Businessreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥439m |
| Cosmetics Businessreportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥2m |
| Regenerative Medicine Related Businessreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥181m |
| Regenerative Medicine Related Businessreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥181m |
| Regenerative Medicine Related Businessreportable segment | segment profit | 2024-04-01 → 2024-09-30 | −¥9m |
| Sustainable Businessreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥3m |
| Sustainable Businessreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥3m |
| Sustainable Businessreportable segment | segment profit | 2024-04-01 → 2024-09-30 | −¥29m |
| —segment total | revenue | 2024-04-01 → 2024-09-30 | ¥1.1bn |
| —segment total | revenue external | 2024-04-01 → 2024-09-30 | ¥1.1bn |
| —segment total | segment profit | 2024-04-01 → 2024-09-30 | −¥26m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 527
| Item | Context | Value | Unit |
|---|---|---|---|
| Net sales | InterimDuration_jpcrp040300-ssr_E05674-000RegenerativeMedicineRelatedBusinessReportableSegmentsMember | 258011000 | JPY |
| Net sales | InterimDuration_jpcrp040300-ssr_E05674-000SustainableBusinessReportableSegmentsMember | 919000 | JPY |
| Net sales | InterimDuration_jpcrp040300-ssr_E05674-000MarketExpansionBusinessReportableSegmentsMember | 1094000 | JPY |
| Net sales | InterimDuration_jpcrp040300-ssr_E05674-000InvestmentBusinessReportableSegmentsMember | 19999000 | JPY |
| Net sales | InterimDuration_jpcrp040300-ssr_E05674-000AITechnologyReportableSegmentsMember | 21538000 | JPY |
| Net sales | InterimDuration_ReportableSegmentsMember | 1270170000 | JPY |
| Net sales | InterimDuration_ReconcilingItemsMember | -4220000 | JPY |
| Net sales | InterimDuration | 1265950000 | JPY |
| Operating income | InterimDuration_jpcrp040300-ssr_E05674-000CosmeticsBusinessReportableSegmentsMember | -84061000 | JPY |
| Operating income | InterimDuration_jpcrp040300-ssr_E05674-000BeautyAndWellnessBusinessReportableSegmentsMember | -39123000 | JPY |
| Operating income | InterimDuration_jpcrp040300-ssr_E05674-000RegenerativeMedicineRelatedBusinessReportableSegmentsMember | -26049000 | JPY |
| Operating income | InterimDuration_jpcrp040300-ssr_E05674-000SustainableBusinessReportableSegmentsMember | -29917000 | JPY |
| Operating income | InterimDuration_jpcrp040300-ssr_E05674-000MarketExpansionBusinessReportableSegmentsMember | -20729000 | JPY |
| Operating income | InterimDuration_jpcrp040300-ssr_E05674-000InvestmentBusinessReportableSegmentsMember | 18280000 | JPY |
| Operating income | InterimDuration_jpcrp040300-ssr_E05674-000AITechnologyReportableSegmentsMember | -66947000 | JPY |
| Operating income | InterimDuration_ReportableSegmentsMember | -248547000 | JPY |
| Operating income | InterimDuration_ReconcilingItemsMember | -74285000 | JPY |
| Operating income | InterimDuration | -322833000 | JPY |
| Document title cover page | FilingDateInstant | Original text (Japanese)半期報告書 | |
| Clause of stipulation cover page | FilingDateInstant | Original text (Japanese)金融商品取引法第24条の５第１項の表の第１号 | |
| Place of filing cover page | FilingDateInstant | Original text (Japanese)関東財務局長 | |
| Filing date cover page | FilingDateInstant | 2025-11-13 | |
| Semi annual accounting period cover page | FilingDateInstant | Original text (Japanese)第36期中（自 2025年４月１日 至 2025年９月30日） | |
| Company name cover page | FilingDateInstant | Original text (Japanese)パス株式会社 | |
| Company name in english cover page | FilingDateInstant | PATH corporation | |
| Title and name of representative cover page | FilingDateInstant | Original text (Japanese)代表取締役CEO 松尾 孝之 | |
| Address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)東京都渋谷区神宮前六丁目17番11号 | |
| Telephone number address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)03（6823）6664（代表） | |
| Name of contact person address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)取締役 星 淳行 | |
| Nearest place of contact cover page | FilingDateInstant | Original text (Japanese)東京都渋谷区神宮前六丁目17番11号 | |
| Telephone number nearest place of contact cover page | FilingDateInstant | Original text (Japanese)03（6823）6664（代表） | |
| Name of contact person nearest place of contact cover page | FilingDateInstant | Original text (Japanese)取締役 星 淳行 | |
| Place for public inspection cover page (text) | FilingDateInstant | Text · Plus | |
| Edinet code | FilingDateInstant | E05674 | |
| Fund code | FilingDateInstant | － | |
| Security code | FilingDateInstant | 38400 | |
| Filer name in japanese | FilingDateInstant | Original text (Japanese)パス株式会社 | |
| Filer name in english | FilingDateInstant | PATH corporation | |
| Fund name in japanese | FilingDateInstant | － | |
| Fund name in english | FilingDateInstant | － | |
| Cabinet office ordinance | FilingDateInstant | Original text (Japanese)企業内容等の開示に関する内閣府令 | |
| Document type | FilingDateInstant | Original text (Japanese)第四号の三様式 | |
| Accounting standards | FilingDateInstant | Japan GAAP | |
| Whether consolidated financial statements are prepared | FilingDateInstant | true | |
| Industry code when consolidated financial statements are prepared in accordance with industry specific regulations | FilingDateInstant | CTE | |
| Industry code when financial statements are prepared in accordance with industry specific regulations | FilingDateInstant | － | |
| Current fiscal year start date | FilingDateInstant | 2025-04-01 | |
| Current period end date | FilingDateInstant | 2025-09-30 | |
| Type of current period | FilingDateInstant | HY | |
| Current fiscal year end date | FilingDateInstant | 2026-03-31 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |